Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesNeuroMetrix Inc

NeuroMetrix Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
None USD 0.00(0%)
Last update at 2025-06-02T13:01:16.176064Z
Market Cap
8.00M

Momentum Score

…

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
2.70
Low
9.20
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
5.90M
Revenue Per Share
5.66
Gross Profit TTM
5.75M
Debt / Equity
0.01
ROE
-30.06%
Net Debt
-1.49M
ROCE
-23.74%
Diluted EPS TTM
-6.30

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -4.42M -2.28M -2.09M -3.77M 0.02M
Net income -4.37M -2.21M -2.00M -3.65M 0.02M
Selling general administrative 4.39M 3.99M 3.52M 5.92M 4.84M
Selling and marketing expenses 2.87M 1.62M 1.44M 4.76M 9.70M
Gross profit 5.75M 5.92M 5.25M 2.25M 7.38M
Reconciled depreciation 0.05M 0.08M 0.09M 0.12M 0.17M
Ebit -4.79M -2.36M -2.18M -11.66M -12.46M
Ebitda -4.74M -2.28M -2.09M -11.53M -12.29M
Depreciation and amortization 0.05M 0.08M 0.09M 0.12M 0.17M
Non operating income net other - - 0.00M 7.76M -
Operating income -4.74M -2.28M -2.09M -11.53M -12.29M
Other operating expenses 13.00M 10.54M 9.47M 20.81M 28.38M
Interest expense -0.33M 0.00M 0.00M 0.00M 0.00M
Interest income 0.33M - - - -
Net interest income 0.33M - - - -
Income tax expense -0.05M -0.08M -0.09M -0.12M 12.32M
Total revenue 8.26M 8.25M 7.38M 9.27M 16.09M
Total operating expenses 10.49M 8.21M 7.34M 13.78M 19.67M
Cost of revenue 2.51M 2.33M 2.13M 7.03M 8.71M
Total other income expense net 0.33M 0.00M 0.00M 7.76M 12.32M
Net income from continuing ops -4.42M -2.28M -2.09M -3.77M 0.02M
Net income applicable to common shares -4.42M -2.28M -2.09M -3.77M 0.02M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 21.42M 24.67M 24.89M 7.99M 6.89M
Other current assets 0.78M 2.91M 1.62M 1.86M 2.30M
Total liab 1.33M 1.31M 1.67M 2.75M 4.36M
Total stockholder equity 20.09M 23.36M 23.22M 5.25M 2.53M
Other current liab 1.24M 0.59M 0.85M 1.54M 2.13M
Common stock 0.00M 0.00M 0.00M 0.00M 0.00M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -210.11M -203.58M -199.16M -196.88M -194.79M
Other assets - - 0.70M 0.72M 0.03M
Cash 1.73M 4.25M 22.57M 5.23M 3.13M
Total current liabilities 1.24M 1.11M 1.37M 2.29M 3.45M
Current deferred revenue -0.36M - - - -
Net debt -1.49M -3.90M -22.27M -4.76M -2.21M
Short term debt 0.15M 0.15M 0.23M 0.60M 0.59M
Short long term debt total 0.24M 0.36M 0.31M 0.46M 0.92M
Other stockholder equity 229.96M 226.93M 222.38M 202.13M 197.32M
Property plant equipment - - 0.67M 0.18M 0.27M
Total current assets 20.85M 24.11M 24.19M 7.09M 5.43M
Net tangible assets - - 23.22M 5.25M 2.53M
Short term investments 16.27M 16.95M - - -
Net receivables 0.52M 0.65M 0.31M 0.33M 0.49M
Inventory 1.56M 1.61M 0.71M 1.05M 1.16M
Accounts payable 0.22M 0.37M 0.28M 0.14M 0.73M
Accumulated other comprehensive income 0.24M - - - -1.23M
Common stock total equity - - - 0.00M 0.00M
Preferred stock total equity - - - 0.00M 0.00M
Retained earnings total equity - - - -196.88M -194.79M
Non currrent assets other 0.03M 0.03M 0.03M 0.03M 0.03M
Non current assets total 0.57M 0.56M 0.70M 0.90M 1.46M
Capital lease obligations 0.24M 0.21M 0.54M 1.06M 1.51M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments 3.11M -16.89M -0.13M -0.01M -0.05M
Change to liabilities - 0.00M 0.14M -1.03M -0.73M
Total cashflows from investing activities - - -0.13M -0.13M -0.05M
Total cash from financing activities 2.33M 3.86M 19.55M 4.17M 0.02M
Change to operating activities - - -1.24M -0.55M -0.52M
Net income -6.53M -4.42M -2.28M -2.09M -3.77M
Change in cash -2.52M -18.32M 17.35M 2.10M -3.65M
Begin period cash flow 4.25M 22.57M 5.23M 3.13M 6.78M
End period cash flow 1.73M 4.25M 22.57M 5.23M 3.13M
Total cash from operating activities -6.08M -5.29M -2.07M -2.07M -3.62M
Issuance of capital stock 2.61M 3.86M 19.55M 4.17M 0.02M
Depreciation 0.06M 0.05M 0.08M 0.09M 0.12M
Change to inventory -0.01M -1.27M -0.15M 0.11M -0.90M
Change to account receivables 0.13M -0.34M 0.02M -0.04M 0.73M
Sale purchase of stock - - - 4.17M 0.02M
Other cashflows from financing activities 2.33M 3.86M 19.55M 0.77M 0.02M
Change to netincome - - 1.36M 0.60M 2.79M
Capital expenditures 0.18M 0.02M 0.13M 0.13M 0.05M
Change receivables - - - -0.04M 0.73M
Cash flows other operating - - - 0.29M -1.87M
Cash and cash equivalents changes - - - 2.10M -3.65M
Change in working capital 0.13M -1.71M -1.23M -1.06M -3.21M
Stock based compensation 0.70M 0.48M 0.70M 0.60M 0.19M
Other non cash items -0.47M 0.31M 0.67M 0.04M 3.05M
Free cash flow -6.27M -5.31M -2.21M -2.07M -3.67M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ABT
Abbott Laboratories		 -0.71
0.65%		 108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 0.28
0.28%		 101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -2.16
0.68%		 316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -
-%		 47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

NeuroMetrix Inc

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

4B Gill Street, Woburn, MA, United States, 01801

781 890 9989

https://www.neurometrix.com

26

Name Title Year Born
Dr. Shai N. Gozani M.D., Ph.D. Founder, Chairman, CEO, Pres & Sec. 1965
Mr. Thomas T. Higgins Sr. VP, CFO & Treasurer 1952
Dr. Xuan Kong Ph.D. Chief Data Scientist NA
Ms. Susan M. Bell R.N. Sr. VP of Population Health & Value Based Care NA
Dr. Shai N. Gozani M.D., Ph.D. Founder, Chairman, CEO, President & Secretary 1965
Mr. Thomas T. Higgins Senior VP, CFO & Treasurer 1952
Ms. Susan M. Bell R.N. Senior Vice President of Population Health & Value Based Care NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…